Aliases & Classifications for Pustulosis of Palm and Sole

MalaCards integrated aliases for Pustulosis of Palm and Sole:

Name: Pustulosis of Palm and Sole 12 15
Psoriasis 44 72
Pustular Psoriasis of the Palms and/or Soles 12
Acrodermatitis Continua of Hallopeau 72
Generalized Pustular Psoriasis 72
Pustulosis of Palms and Soles 72
Palmoplantar Pustulosis 12
Acropustulosis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4398
MeSH 44 D011565
NCIt 50 C34888
SNOMED-CT 68 27520001
ICD10 33 L40.3
UMLS 72 C0030246 C0033860 C0343055 more

Summaries for Pustulosis of Palm and Sole

MalaCards based summary : Pustulosis of Palm and Sole, also known as psoriasis, is related to impetigo herpetiformis and psoriasis 14, pustular, and has symptoms including pruritus, exanthema and psoriasiform rash. An important gene associated with Pustulosis of Palm and Sole is MRAP (Melanocortin 2 Receptor Accessory Protein), and among its related pathways/superpathways are NF-KappaB Family Pathway and Innate Lymphoid Cell Differentiation Pathways. The drugs Esomeprazole and Dapsone have been mentioned in the context of this disorder. Affiliated tissues include skin, t cells and testes.

Related Diseases for Pustulosis of Palm and Sole

Diseases related to Pustulosis of Palm and Sole via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1222, show less)
# Related Disease Score Top Affiliating Genes
1 impetigo herpetiformis 33.0 IL36RN CARD14
2 psoriasis 14, pustular 32.5 IL36RN AP1S3
3 geographic tongue 32.4 TNF IL36RN
4 spondylitis 31.1 TNFRSF1B TNF
5 pustular psoriasis 31.1 TNF IL36RN CARD14 AP1S3
6 psoriasis 31.0 TNF IL36RN CARD14
7 pustulosis palmaris et plantaris 30.9 TNF IL36RN CCR6 AP1S3
8 bone inflammation disease 30.9 TNFRSF1B TNF MRAP
9 tenosynovitis 30.6 TNFRSF1B MRAP
10 nasopharyngitis 30.6 TNFRSF1B IL36RN
11 skin disease 30.5 TNF IL36RN CARD14
12 spondyloarthropathy 1 30.4 TNFRSF1B TNF MRAP
13 iritis 30.4 TNFRSF1B MRAP
14 psoriatic arthritis 30.4 TNFRSF1B TNF IL36RN
15 pityriasis rubra pilaris 30.4 TNFRSF1B IL36RN CARD14
16 pyoderma 30.3 TNF IL36RN
17 acrodermatitis 30.2 IL36RN AP1S3
18 exanthem 30.2 TNFRSF1B TNF
19 subcorneal pustular dermatosis 30.2 TNFRSF1B IL36RN
20 skin sarcoidosis 30.0 TNFRSF1B TNF
21 orbital plasma cell granuloma 29.9 TNFRSF1B MRAP
22 posterior scleritis 29.6 TNF MRAP
23 panuveitis 29.4 TNFRSF1B TNF MRAP
24 periodic fever, familial, autosomal dominant 29.4 TNFRSF1B TNF
25 guillain-barre syndrome 29.4 TNFRSF1B TNF
26 juvenile rheumatoid arthritis 29.3 TNFRSF1B TNF
27 melkersson-rosenthal syndrome 29.2 TNFRSF1B TNF
28 palindromic rheumatism 29.1 TNFRSF1B TNF MRAP
29 behcet syndrome 29.0 TNFRSF1B TNF MRAP
30 psoriasis 13 12.7
31 psoriasis 7 12.7
32 psoriasis 11 12.7
33 psoriasis 2 12.6
34 psoriasis 15, pustular 12.6
35 psoriasis 4 12.6
36 psoriasis 3 12.6
37 psoriasis 10 12.6
38 psoriasis 6 12.5
39 psoriasis 5 12.5
40 psoriasis 12 12.5
41 psoriasis 8 12.5
42 psoriasis 9 12.5
43 mental retardation and psoriasis 12.3
44 tranebjaerg svejgaard syndrome 12.1
45 psoriatic juvenile idiopathic arthritis 11.9
46 psoriasis 1 11.7
47 parapsoriasis 11.5
48 vitiligo-associated multiple autoimmune disease susceptibility 1 11.5
49 subacute cutaneous lupus erythematosus 11.4
50 temporomandibular ankylosis 11.4
51 singleton-merten syndrome 1 11.2
52 systemic onset juvenile idiopathic arthritis 11.2
53 nail disorder, nonsyndromic congenital, 1 11.1
54 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 11.1
55 singleton-merten syndrome 2 11.1
56 primary cutaneous amyloidosis 11.1
57 combined immunodeficiency with skin granulomas 11.1
58 singleton-merten syndrome 11.1
59 polycystic kidney disease 10.7
60 skin carcinoma 10.6
61 lipid metabolism disorder 10.6
62 hyperostosis 10.6
63 vitiligo-associated multiple autoimmune disease susceptibility 6 10.6
64 inflammatory spondylopathy 10.6
65 scabies 10.5
66 bullous pemphigoid 10.5
67 lichen planus 10.5
68 tonsillitis 10.5
69 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.5
70 body mass index quantitative trait locus 1 10.5
71 nail disease 10.5
72 neurofibromatosis, type ii 10.4
73 arthritis 10.4
74 pompholyx 10.4
75 fatty liver disease 10.4
76 ulcerative colitis 10.4
77 non-alcoholic fatty liver disease 10.4
78 metal allergy 10.4
79 seborrheic dermatitis 10.4
80 dermatitis, atopic 10.4
81 hypereosinophilic syndrome 10.4
82 hepatitis c 10.4
83 vascular disease 10.4
84 liver disease 10.4
85 atherosclerosis susceptibility 10.4
86 neurodermatitis 10.4
87 chronic orbital inflammation 10.4 TNFRSF1B MRAP
88 basal cell carcinoma 10.4
89 autoimmune disease 10.4
90 sapho syndrome 10.4
91 synovitis 10.4
92 spondylarthropathy 10.4
93 ichthyosis 10.4
94 severe combined immunodeficiency 10.4
95 ige responsiveness, atopic 10.3
96 allergic contact dermatitis 10.3
97 herpes zoster 10.3
98 transient arthritis 10.3 TNFRSF1B MRAP
99 immune deficiency disease 10.3
100 skin atrophy 10.3
101 dermatophytosis 10.3
102 body mass index quantitative trait locus 11 10.3
103 systemic lupus erythematosus 10.3
104 body mass index quantitative trait locus 9 10.3
105 body mass index quantitative trait locus 8 10.3
106 body mass index quantitative trait locus 4 10.3
107 body mass index quantitative trait locus 10 10.3
108 body mass index quantitative trait locus 7 10.3
109 body mass index quantitative trait locus 12 10.3
110 body mass index quantitative trait locus 14 10.3
111 body mass index quantitative trait locus 18 10.3
112 body mass index quantitative trait locus 19 10.3
113 body mass index quantitative trait locus 20 10.3
114 anterior scleritis 10.3 TNFRSF1B MRAP
115 48,xyyy 10.3
116 osteomyelitis 10.3
117 rheumatic disease 10.3
118 enthesopathy 10.3
119 dermatitis 10.3
120 arthropathy 10.3
121 osteoarthritis 10.3
122 sarcoidosis 1 10.3
123 leprosy 3 10.3
124 anxiety 10.3
125 squamous cell carcinoma 10.3
126 lymphopenia 10.3
127 hansen's disease 10.3
128 hepatitis c virus 10.3
129 vasculitis 10.3
130 alcohol dependence 10.3
131 alcohol use disorder 10.3
132 hidradenitis 10.3
133 depression 10.3
134 multiple sclerosis 10.3
135 hidradenitis suppurativa 10.3
136 kidney disease 10.3
137 47,xyy 10.3
138 diarrhea 10.2
139 nevus, epidermal 10.2
140 alexithymia 10.2
141 gout 10.2
142 papilloma 10.2
143 acute generalized exanthematous pustulosis 10.2
144 hypertriglyceridemia, familial 10.2
145 sleep apnea 10.2
146 hyperuricemia 10.2
147 hepatitis b 10.2
148 dermatomyositis 10.2
149 chronic kidney disease 10.2
150 periodontitis 10.2
151 amyloidosis 10.2
152 melanoma 10.2
153 systemic scleroderma 10.2
154 rosacea 10.2
155 kaposi sarcoma 10.2
156 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.2
157 pulmonary alveolar microlithiasis 10.2
158 colitis 10.2
159 fissured tongue 10.2
160 pharyngitis 10.2
161 syphilis 10.2
162 chickenpox 10.2
163 celiac disease 1 10.2
164 mycosis fungoides 10.2
165 proteasome-associated autoinflammatory syndrome 1 10.2
166 inflammatory bowel disease 10.2
167 crohn's colitis 10.2
168 spondyloarthropathy 10.2
169 chlamydia 10.2
170 keratosis 10.2
171 iga glomerulonephritis 10.2
172 hypertrichosis 10.2
173 reactive arthritis 10.2
174 crohn's disease 10.2
175 meningitis 10.2
176 alopecia 10.2
177 arteries, anomalies of 10.2
178 hyperlipoproteinemia, type iii 10.2
179 sexual disorder 10.2
180 coronary artery anomaly 10.2
181 neutropenia 10.2
182 scleroderma, familial progressive 10.2
183 congestive heart failure 10.2
184 cerebrovascular disease 10.2
185 pulmonary disease, chronic obstructive 10.2
186 impotence 10.2
187 viral hepatitis 10.2
188 diffuse infiltrative lymphocytosis syndrome 10.2 TNF MRAP
189 hypercholesterolemia, familial, 1 10.1
190 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 10.1
191 erythema multiforme 10.1
192 porokeratosis 10.1
193 inflammatory linear verrucous epidermal nevus 10.1
194 granulomatous dermatitis 10.1 TNFRSF1B TNF
195 chronic gonococcal salpingitis 10.1 TNFRSF1B TNF
196 coronary heart disease 1 10.1
197 graft-versus-host disease 10.1
198 hypoparathyroidism 10.1
199 hepatitis 10.1
200 pneumonia 10.1
201 acquired immunodeficiency syndrome 10.1
202 anterior uveitis 10.1
203 fibrosis of extraocular muscles, congenital, 1 10.1
204 telangiectasis 10.1
205 opisthorchiasis 10.1
206 demyelinating disease 10.1
207 cellulitis 10.1
208 sleep disorder 10.1
209 progressive multifocal leukoencephalopathy 10.1
210 pemphigus foliaceus 10.1
211 peroneal neuropathy 10.1 TNFRSF1B TNF
212 human immunodeficiency virus type 1 10.1
213 cheilitis 10.1
214 purpura 10.1
215 pityriasis rosea 10.1
216 cutaneous candidiasis 10.1
217 bacterial infectious disease 10.1
218 candidiasis 10.1
219 mouth disease 10.1
220 osteoporosis 10.1
221 bone mineral density quantitative trait locus 8 10.1
222 bone mineral density quantitative trait locus 15 10.1
223 peripheral vascular disease 10.1
224 sarcoma 10.1
225 glossitis 10.1
226 thrombocytopenia 10.1
227 spindle cell sarcoma 10.1
228 b-cell lymphoma 10.1
229 discoid lupus erythematosus 10.1
230 coccidiosis 10.1 TNF MRAP
231 glaucomatocyclitic crisis 10.1 TNF MRAP
232 asthma 10.1
233 cutaneous lupus erythematosus 10.1
234 squamous cell papilloma 10.1
235 idiopathic interstitial pneumonia 10.1
236 pulmonary fibrosis 10.1
237 herpes simplex 10.1
238 chronic salpingitis 10.1 TNFRSF1B TNF
239 conjunctival disease 10.1 TNF MRAP
240 post-transplant lymphoproliferative disease 10.1 TNFRSF1B TNF
241 lentigines 10.1
242 myocardial infarction 10.1
243 deficiency anemia 10.1
244 tinea pedis 10.1
245 end stage renal failure 10.1
246 lung disease 10.1
247 measles 10.1
248 hashimoto thyroiditis 10.1
249 leukemia, acute monocytic 10.1
250 myositis 10.1
251 pemphigus vulgaris, familial 10.1
252 palmoplantar keratoderma, punctate type ii 10.1
253 dowling-degos disease 1 10.1
254 rheumatoid arthritis 10.1
255 hypervitaminosis a 10.1
256 ocular motor apraxia 10.1
257 chronic recurrent multifocal osteomyelitis 10.1
258 sjogren syndrome 10.1
259 helicobacter pylori infection 10.1
260 nail disorder, nonsyndromic congenital, 10 10.1
261 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.1
262 adult t-cell leukemia 10.1
263 lymphoma 10.1
264 cutaneous t cell lymphoma 10.1
265 psoriasis 15 10.1
266 sensorineural hearing loss 10.1
267 streptococcal meningitis 10.1
268 allergic hypersensitivity disease 10.1
269 primary biliary cirrhosis 10.1
270 leukemia 10.1
271 uveitis 10.1
272 haverhill fever 10.1
273 facial paralysis 10.1
274 hypothyroidism 10.1
275 urticaria 10.1
276 dental caries 10.1
277 relapsing polychondritis 10.1
278 contact dermatitis 10.1
279 glomerulonephritis 10.1
280 necrobiosis lipoidica 10.1
281 folliculitis 10.1
282 thyroid gland disease 10.1
283 liver cirrhosis 10.1
284 hydrarthrosis 10.1
285 t-cell adult acute lymphocytic leukemia 10.1
286 t-cell leukemia 10.1
287 thyroiditis 10.1
288 hyperthyroidism 10.1
289 impetigo 10.1
290 monocytic leukemia 10.1
291 pyoderma gangrenosum 10.1
292 lupus erythematosus 10.1
293 pemphigus 10.1
294 diabetes mellitus 10.1
295 neurofibroma 10.1
296 alopecia areata 10.1
297 acute monoblastic leukemia 10.1
298 cytokine deficiency 10.1
299 eosinophilic pustular folliculitis 10.1
300 guttate psoriasis 10.1
301 leukemia, t-cell, chronic 10.1
302 primary biliary cholangitis 10.1
303 punctate porokeratosis 10.1
304 pik3ca-related overgrowth syndrome 10.1
305 hematopoietic stem cell transplantation 10.1
306 inclusion conjunctivitis 10.0 TNF MRAP
307 ichthyosis vulgaris 10.0
308 mycobacterium tuberculosis 1 10.0
309 atrial fibrillation 10.0
310 non-alcoholic steatohepatitis 10.0
311 pancytopenia 10.0
312 epidermolysis bullosa 10.0
313 irritant dermatitis 10.0
314 mood disorder 10.0
315 hyperglycemia 10.0
316 connective tissue disease 10.0
317 dermatitis herpetiformis 10.0
318 actinic keratosis 10.0
319 bowen's disease 10.0
320 exfoliative dermatitis 10.0
321 renal cell carcinoma, nonpapillary 10.0
322 lung cancer 10.0
323 dermatitis herpetiformis, familial 10.0
324 homocysteinemia 10.0
325 kawasaki disease 10.0
326 microcephaly, epilepsy, and diabetes syndrome 10.0
327 paronychia 10.0
328 norwegian scabies 10.0
329 capillary leak syndrome 10.0
330 hyperinsulinism 10.0
331 ankylosis 10.0
332 secondary syphilis 10.0
333 epidermolysis bullosa acquisita 10.0
334 spongiotic dermatitis 10.0
335 eye disease 10.0
336 localized scleroderma 10.0
337 hypoglycemia 10.0
338 acute respiratory distress syndrome 10.0
339 splenomegaly 10.0
340 stevens-johnson syndrome/toxic epidermal necrolysis 10.0
341 systemic capillary leak syndrome 10.0
342 colorectal cancer 10.0
343 neutrophil migration 10.0
344 benign chronic pemphigus 10.0
345 pulmonary fibrosis, idiopathic 10.0
346 down syndrome 10.0
347 lymphoma, hodgkin, classic 10.0
348 lymphoma, non-hodgkin, familial 10.0
349 allergic rhinitis 10.0
350 membranous nephropathy 10.0
351 tetanus 10.0
352 heart disease 10.0
353 polyneuropathy 10.0
354 toxic shock syndrome 10.0
355 oral candidiasis 10.0
356 gonadal dysgenesis 10.0
357 cholecystitis 10.0
358 acute kidney failure 10.0
359 turner syndrome 10.0
360 rhinitis 10.0
361 neuropathy 10.0
362 parasitic helminthiasis infectious disease 10.0
363 cholangitis 10.0
364 periodontitis, chronic 10.0
365 major affective disorder 8 10.0
366 major affective disorder 9 10.0
367 diffuse alopecia areata 10.0
368 nephrotic syndrome 10.0
369 pulmonary sarcoidosis 10.0
370 personality disorder 10.0
371 relapsing-remitting multiple sclerosis 10.0
372 bipolar disorder 10.0
373 conjunctivitis 10.0
374 myeloid leukemia 10.0
375 stomatitis 10.0
376 stromal keratitis 9.9 TNF CCR6
377 cogan syndrome 9.9 TNFRSF1B TNF
378 hepatocellular carcinoma 9.9
379 migraine with or without aura 1 9.9
380 atrial standstill 1 9.9
381 porokeratosis 1, multiple types 9.9
382 small cell cancer of the lung 9.9
383 triiodothyronine receptor auxiliary protein 9.9
384 alopecia universalis congenita 9.9
385 myeloma, multiple 9.9
386 taqi polymorphism 9.9
387 leukemia, chronic myeloid 9.9
388 angina pectoris 9.9
389 restless legs syndrome 9.9
390 mucositis 9.9
391 osteomalacia 9.9
392 diphtheria 9.9
393 tinea corporis 9.9
394 cholestasis 9.9
395 avoidant personality disorder 9.9
396 mental depression 9.9
397 histoplasmosis 9.9
398 autoimmune hepatitis 9.9
399 palmoplantar keratosis 9.9
400 mesangial proliferative glomerulonephritis 9.9
401 human immunodeficiency virus infectious disease 9.9
402 combined t cell and b cell immunodeficiency 9.9
403 scarlet fever 9.9
404 molluscum contagiosum 9.9
405 hard palate cancer 9.9
406 erythrokeratoderma ''en cocardes'' 9.9
407 pityriasis lichenoides 9.9
408 back pain 9.9
409 breast cancer 9.9
410 hypertension, essential 9.9
411 keratitis, hereditary 9.9
412 neurofibromatosis, type iv, of riccardi 9.9
413 thrombophilia due to thrombin defect 9.9
414 epidermodysplasia verruciformis 1 9.9
415 familial mediterranean fever 9.9
416 insulin-like growth factor i 9.9
417 gallbladder disease 1 9.9
418 kala-azar 1 9.9
419 severe cutaneous adverse reaction 9.9
420 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.9
421 thrombosis 9.9
422 bone resorption disease 9.9
423 hypopyon 9.9
424 common cold 9.9
425 glucose intolerance 9.9
426 erysipelas 9.9
427 alcoholic hepatitis 9.9
428 dilated cardiomyopathy 9.9
429 balanitis 9.9
430 porphyria 9.9
431 disease of mental health 9.9
432 clear cell acanthoma 9.9
433 acanthoma 9.9
434 hypogonadism 9.9
435 kidney cancer 9.9
436 pulmonary tuberculosis 9.9
437 interstitial lung disease 9.9
438 scalp dermatosis 9.9
439 keratoacanthoma 9.9
440 ischemia 9.9
441 vaccinia 9.9
442 granuloma annulare 9.9
443 proliferative glomerulonephritis 9.9
444 hypogonadotropism 9.9
445 gastrointestinal system disease 9.9
446 cataract 9.9
447 influenza 9.9
448 eating disorder 9.9
449 leishmaniasis 9.9
450 eczema herpeticum 9.9
451 iridocyclitis 9.9
452 blepharitis 9.9
453 fasciitis 9.9
454 acute graft versus host disease 9.9
455 lichen sclerosus 9.9
456 pityriasis lichenoides chronica 9.9
457 pseudoainhum 9.9
458 chronic actinic dermatitis 9.9
459 erythema multiforme major 9.9
460 overgrowth syndrome 9.9
461 juvenile ankylosing spondylitis 9.9 TNFRSF1B TNF MRAP
462 scleral disease 9.9 TNFRSF1B TNF MRAP
463 acute salpingitis 9.8 TNFRSF1B TNF MRAP
464 hypersensitivity reaction type iv disease 9.8 TNFRSF1B TNF MRAP
465 uveal disease 9.8 TNFRSF1B TNF MRAP
466 alopecia, androgenetic, 1 9.8
467 annular erythema 9.8
468 acroosteolysis 9.8
469 myasthenia gravis 9.8
470 stroke, ischemic 9.8
471 resting heart rate, variation in 9.8
472 fatty liver disease, nonalcoholic 1 9.8
473 leptin deficiency or dysfunction 9.8
474 immunodeficiency, common variable, 10 9.8
475 hydrops, lactic acidosis, and sideroblastic anemia 9.8
476 androgenic alopecia 9.8
477 pollen allergy 9.8
478 spinal disease 9.8
479 autosomal recessive congenital ichthyosis 9.8
480 lymphoproliferative syndrome 9.8
481 polycystic ovary syndrome 9.8
482 keratoconjunctivitis sicca 9.8
483 focal segmental glomerulosclerosis 9.8
484 megaloblastic anemia 9.8
485 generalized anxiety disorder 9.8
486 retinal vein occlusion 9.8
487 arteriosclerosis 9.8
488 iron metabolism disease 9.8
489 acute pancreatitis 9.8
490 adenocarcinoma 9.8
491 gingivitis 9.8
492 aortic aneurysm 9.8
493 hair disease 9.8
494 uremia 9.8
495 poliomyelitis 9.8
496 pancreatitis 9.8
497 demyelinating polyneuropathy 9.8
498 peripheral nervous system disease 9.8
499 bronchitis 9.8
500 diffuse idiopathic skeletal hyperostosis 9.8
501 monoclonal gammopathy of uncertain significance 9.8
502 peptic ulcer disease 9.8
503 placenta disease 9.8
504 septic arthritis 9.8
505 subacute delirium 9.8
506 pityriasis versicolor 9.8
507 keratoconjunctivitis 9.8
508 pulmonary embolism 9.8
509 chronic graft versus host disease 9.8
510 chronic inflammatory demyelinating polyneuropathy 9.8
511 homologous wasting disease 9.8
512 lichen planopilaris 9.8
513 autonomic dysfunction 9.8
514 cytomegalovirus infection 9.8
515 paresthesia 9.8
516 rapidly involuting congenital hemangioma 9.8
517 lymphedema 9.8
518 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.8
519 thyroid carcinoma 9.8
520 apnea, obstructive sleep 9.8
521 porphyria cutanea tarda 9.8
522 schizophrenia 9.8
523 keratosis, seborrheic 9.8
524 temporal arteritis 9.8
525 anemia, autoimmune hemolytic 9.8
526 diabetes mellitus, insulin-dependent 9.8
527 myeloperoxidase deficiency 9.8
528 netherton syndrome 9.8
529 pituitary adenoma, prolactin-secreting 9.8
530 leukemia, acute myeloid 9.8
531 branchiootic syndrome 1 9.8
532 huntington disease-like 3 9.8
533 cone-rod synaptic disorder, congenital nonprogressive 9.8
534 alpha-1-antitrypsin deficiency 9.8
535 hypophosphatemia 9.8
536 hyperphosphatemia 9.8
537 extrapulmonary tuberculosis 9.8
538 bone disease 9.8
539 mumps 9.8
540 endocarditis 9.8
541 lymphocytic leukemia 9.8
542 pre-eclampsia 9.8
543 fanconi syndrome 9.8
544 myiasis 9.8
545 anogenital venereal wart 9.8
546 pulmonary edema 9.8
547 mitral valve insufficiency 9.8
548 conn's syndrome 9.8
549 optic neuritis 9.8
550 common variable immunodeficiency 9.8
551 secondary hyperparathyroidism 9.8
552 acute kidney tubular necrosis 9.8
553 dementia 9.8
554 hyperparathyroidism 9.8
555 eclampsia 9.8
556 frozen shoulder 9.8
557 childhood type dermatomyositis 9.8
558 oligospermia 9.8
559 panniculitis 9.8
560 thrombocytopenia due to platelet alloimmunization 9.8
561 neuritis 9.8
562 calcinosis 9.8
563 drug-induced hepatitis 9.8
564 thrombocytosis 9.8
565 central retinal vein occlusion 9.8
566 agammaglobulinemia 9.8
567 hairy cell leukemia 9.8
568 cryoglobulinemia 9.8
569 bursitis 9.8
570 substance abuse 9.8
571 lipomatosis 9.8
572 mammary paget's disease 9.8
573 gastritis 9.8
574 pseudohypoparathyroidism 9.8
575 hemolytic anemia 9.8
576 fibromyalgia 9.8
577 inverted follicular keratosis 9.8
578 polycythemia 9.8
579 in situ carcinoma 9.8
580 skin melanoma 9.8
581 hemophilia 9.8
582 keloid disorder 9.8
583 central serous chorioretinopathy 9.8
584 granulocytopenia 9.8
585 leukoplakia 9.8
586 polymyositis 9.8
587 superficial spreading melanoma 9.8
588 raynaud phenomenon 9.8
589 familial pityriasis rubra pilaris 9.8
590 aneurysm 9.8
591 chronic pain 9.8
592 headache 9.8
593 pituitary tumors 9.8
594 posttransplant acute limbic encephalitis 9.8
595 anti-p200 pemphigoid 9.8
596 epidermal disease 9.8
597 aortic aneurysm, familial abdominal, 1 9.7
598 acanthosis nigricans 9.7
599 cardiac arrhythmia 9.7
600 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.7
601 factor viii deficiency 9.7
602 lymphoma, mucosa-associated lymphoid type 9.7
603 geographic and fissured tongue 9.7
604 leukemia, chronic lymphocytic 9.7
605 epidermolytic hyperkeratosis 9.7
606 gastroesophageal reflux 9.7
607 otitis media 9.7
608 prostate cancer 9.7
609 pulmonary hypertension, primary, 1 9.7
610 thrombocytopenic purpura, autoimmune 9.7
611 thyroid cancer, nonmedullary, 1 9.7
612 tobacco addiction 9.7
613 arterial calcification, generalized, of infancy, 1 9.7
614 hemochromatosis, type 1 9.7
615 myelofibrosis 9.7
616 polycythemia vera 9.7
617 xeroderma pigmentosum, variant type 9.7
618 hemophilia a 9.7
619 aging 9.7
620 macular degeneration, age-related, 1 9.7
621 dermatitis, atopic, 2 9.7
622 huntington disease-like 2 9.7
623 major depressive disorder 9.7
624 aplastic anemia 9.7
625 smoking as a quantitative trait locus 3 9.7
626 acute promyelocytic leukemia 9.7
627 lung cancer susceptibility 3 9.7
628 microvascular complications of diabetes 3 9.7
629 microvascular complications of diabetes 4 9.7
630 microvascular complications of diabetes 6 9.7
631 microvascular complications of diabetes 7 9.7
632 osteomyelitis, sterile multifocal, with periostitis and pustulosis 9.7
633 aspergillosis 9.7
634 myelodysplastic syndrome 9.7
635 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.7
636 aortic valve disease 2 9.7
637 leukemia, acute lymphoblastic 3 9.7
638 chronic ulcer of skin 9.7
639 tendinitis 9.7
640 autoimmune uveitis 9.7
641 diffuse large b-cell lymphoma 9.7
642 marginal zone b-cell lymphoma 9.7
643 secondary progressive multiple sclerosis 9.7
644 follicular lymphoma 9.7
645 immunoglobulin alpha deficiency 9.7
646 ductal carcinoma in situ 9.7
647 lymphocytic colitis 9.7
648 angular cheilitis 9.7
649 zika fever 9.7
650 latex allergy 9.7
651 venous insufficiency 9.7
652 dry eye syndrome 9.7
653 osteonecrosis 9.7
654 cholelithiasis 9.7
655 charcot-marie-tooth disease 9.7
656 interstitial nephritis 9.7
657 renal hypertension 9.7
658 portal hypertension 9.7
659 thrombotic thrombocytopenic purpura 9.7
660 filariasis 9.7
661 lepromatous leprosy 9.7
662 tooth disease 9.7
663 lipoid nephrosis 9.7
664 discitis 9.7
665 respiratory failure 9.7
666 keratomalacia 9.7
667 epidural abscess 9.7
668 tinea cruris 9.7
669 pulmonary alveolar proteinosis 9.7
670 chagas disease 9.7
671 goiter 9.7
672 vogt-koyanagi-harada disease 9.7
673 posterior uveitis 9.7
674 balanoposthitis 9.7
675 acquired hyperkeratosis 9.7
676 tinea manuum 9.7
677 urethritis 9.7
678 scleritis 9.7
679 alcoholic liver cirrhosis 9.7
680 autoimmune polyendocrine syndrome 9.7
681 prostatitis 9.7
682 chromoblastomycosis 9.7
683 dermatomycosis 9.7
684 conjunctival squamous cell carcinoma 9.7
685 pericarditis 9.7
686 optic nerve disease 9.7
687 telogen effluvium 9.7
688 exostosis 9.7
689 chronic mucocutaneous candidiasis 9.7
690 hereditary multiple exostoses 9.7
691 constipation 9.7
692 vulvovaginitis 9.7
693 gastroenteritis 9.7
694 psychotic disorder 9.7
695 transitional cell carcinoma 9.7
696 bruxism 9.7
697 immune system disease 9.7
698 membranoproliferative glomerulonephritis 9.7
699 gingival overgrowth 9.7
700 fibrosarcoma 9.7
701 mixed connective tissue disease 9.7
702 mastocytosis 9.7
703 thrombophlebitis 9.7
704 thyroid gland papillary carcinoma 9.7
705 heart valve disease 9.7
706 primary syphilis 9.7
707 myopathy 9.7
708 coronary stenosis 9.7
709 superficial basal cell carcinoma 9.7
710 cutaneous fibrous histiocytoma 9.7
711 macular retinal edema 9.7
712 neurotic disorder 9.7
713 elephantiasis 9.7
714 adjustment disorder 9.7
715 aortitis 9.7
716 aortic valve insufficiency 9.7
717 eosinophilic pneumonia 9.7
718 adenoma 9.7
719 chronic fatigue syndrome 9.7
720 multiple carboxylase deficiency 9.7
721 chorioretinitis 9.7
722 erythematosquamous dermatosis 9.7
723 visceral leishmaniasis 9.7
724 splenic tuberculosis 9.7
725 lipid storage disease 9.7
726 plantar fasciitis 9.7
727 aphthous stomatitis 9.7
728 yellow fever 9.7
729 irritable bowel syndrome 9.7
730 periostitis 9.7
731 myotonic dystrophy 9.7
732 hereditary multiple osteochondromas 9.7
733 hypertrophic cardiomyopathy 9.7
734 sickle cell disease 9.7
735 acquired hemophilia 9.7
736 al amyloidosis 9.7
737 allergic encephalomyelitis 9.7
738 amyloidosis aa 9.7
739 carcinoid syndrome 9.7
740 carcinoma showing thymus-like differentiation 9.7
741 ichthyosis, acquired 9.7
742 leukemia, b-cell, chronic 9.7
743 linear lichen planus 9.7
744 mycobacterium marinum 9.7
745 myotonia atrophica 9.7
746 oral lichen planus 9.7
747 prurigo nodularis 9.7
748 pyogenic granuloma 9.7
749 streptococcal group a invasive disease 9.7
750 sudden sensorineural hearing loss 9.7
751 zika virus infection 9.7
752 b-cell non-hodgkin lymphoma 9.7
753 systemic autoimmune disease 9.7
754 inflammatory myopathy with abundant macrophages 9.7
755 autosomal dominant epidermolytic ichthyosis 9.7
756 avascular necrosis 9.7
757 iga pemphigus 9.7
758 acute liver failure 9.7
759 hyperpigmentation of the skin 9.7
760 glomerular disease 9.7
761 autoinflammatory syndrome 9.7
762 primary adrenal insufficiency 9.7
763 cutaneous myiasis 9.7
764 primary bacterial infectious disease 9.7 TNFRSF1B TNF
765 bladder cancer 9.5
766 cardiac conduction defect 9.5
767 charcot-marie-tooth disease, demyelinating, type 1a 9.5
768 cleidocranial dysplasia 9.5
769 darier-white disease 9.5
770 dupuytren contracture 9.5
771 hair whorl 9.5
772 attention deficit-hyperactivity disorder 9.5
773 hypercalciuria, absorptive, 2 9.5
774 palmoplantar keratoderma, epidermolytic 9.5
775 immunoglobulin e concentration, serum 9.5
776 keloid formation 9.5
777 leiomyoma, uterine 9.5
778 lipomatosis, multiple 9.5
779 mastocytosis, cutaneous 9.5
780 myelopathy, htlv-1-associated 9.5
781 felty syndrome 9.5
782 fanconi renotubular syndrome 1 9.5
783 pilomatrixoma 9.5
784 epidermoid cysts 9.5
785 dyschromatosis symmetrica hereditaria 9.5
786 diabetes mellitus, noninsulin-dependent 9.5
787 cryoglobulinemia, familial mixed 9.5
788 leukocyte adhesion deficiency, type i 9.5
789 basal cell nevus syndrome 9.5
790 arthritis, sacroiliac 9.5
791 ainhum 9.5
792 acrokeratosis verruciformis 9.5
793 neuropathy, hereditary, with liability to pressure palsies 9.5
794 noonan syndrome 1 9.5
795 ovarian cancer 9.5
796 paget disease, extramammary 9.5
797 polykaryocytosis inducer 9.5
798 actinic prurigo 9.5
799 pulmonary hemosiderosis 9.5
800 neural tube defects 9.5
801 spondyloarthropathy 2 9.5
802 strabismus 9.5
803 chromosome 2q35 duplication syndrome 9.5
804 syringomyelia, noncommunicating isolated 9.5
805 thrombophilia due to activated protein c resistance 9.5
806 digeorge syndrome 9.5
807 trigeminal neuralgia 9.5
808 urate oxidase, pseudogene 9.5
809 varicose veins 9.5
810 whim syndrome 9.5
811 wilms tumor 1 9.5
812 alkaptonuria 9.5
813 chondrodysplasia punctata syndrome 9.5
814 chondrosarcoma 9.5
815 pituitary adenoma 4, acth-secreting 9.5
816 eosinophilic fasciitis 9.5
817 goodpasture syndrome 9.5
818 hutterite cerebroosteonephrodysplasia syndrome 9.5
819 hypoadrenocorticism, familial 9.5
820 acetylation, slow 9.5
821 moyamoya disease 1 9.5
822 holocarboxylase synthetase deficiency 9.5
823 myxedema 9.5
824 pulmonic stenosis 9.5
825 retinitis pigmentosa 9.5
826 short stature-obesity syndrome 9.5
827 tardive dyskinesia 9.5
828 restrictive dermopathy, lethal 9.5
829 tinea imbricata 9.5
830 hypomelanosis of ito 9.5
831 chondrodysplasia punctata 2, x-linked dominant 9.5
832 congenital hemidysplasia with ichthyosiform erythroderma and limb defects 9.5
833 ichthyosis, x-linked 9.5
834 incontinentia pigmenti 9.5
835 glaucoma-related pigment dispersion syndrome 9.5
836 wilms tumor 5 9.5
837 autoimmune lymphoproliferative syndrome 9.5
838 malignant atrophic papulosis 9.5
839 ossification of the posterior longitudinal ligament of spine 9.5
840 wilson disease 9.5
841 werner syndrome 9.5
842 acromelic frontonasal dysostosis 9.5
843 sickle cell anemia 9.5
844 reflex sympathetic dystrophy 9.5
845 brooke-spiegler syndrome 9.5
846 systemic lupus erythematosus 3 9.5
847 abdominal obesity-metabolic syndrome 1 9.5
848 dermatitis, atopic, 3 9.5
849 dermatitis, atopic, 4 9.5
850 birdshot chorioretinopathy 9.5
851 dermatitis, atopic, 5 9.5
852 alveolar soft part sarcoma 9.5
853 nasopharyngeal carcinoma 9.5
854 creatinine clearance quantitative trait locus 9.5
855 dermatofibrosarcoma protuberans 9.5
856 hypertensive nephropathy 9.5
857 neutrophilic dermatosis, acute febrile 9.5
858 autoimmune disease 3 9.5
859 legionnaire disease 9.5
860 lung cancer susceptibility 1 9.5
861 chilblain lupus 1 9.5
862 intraocular pressure quantitative trait locus 9.5
863 celiac disease 6 9.5
864 peripapillary atrophy, beta type 9.5
865 lipoprotein glomerulopathy 9.5
866 diabetes mellitus, ketosis-prone 9.5
867 myd88 deficiency 9.5
868 inflammatory bowel disease 17 9.5
869 microvascular complications of diabetes 5 9.5
870 trichotillomania 9.5
871 dermatitis, atopic, 9 9.5
872 ectodermal dysplasia-syndactyly syndrome 2 9.5
873 gastric cancer 9.5
874 okt4 epitope deficiency 9.5
875 cfhr5 deficiency 9.5
876 human herpesvirus 8 9.5
877 erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige 9.5
878 bardet-biedl syndrome 7 9.5
879 thrombocytopenia 5 9.5
880 brown syndrome 9.5
881 autoinflammatory syndrome, familial, behcet-like 9.5
882 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.5
883 epidermodysplasia verruciformis 2 9.5
884 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.5
885 tendinopathy 9.5
886 pulmonary hypertension 9.5
887 chikungunya 9.5
888 hemophagocytic lymphohistiocytosis 9.5
889 cryptogenic organizing pneumonia 9.5
890 epstein-barr virus hepatitis 9.5
891 variola major 9.5
892 mantle cell lymphoma 9.5
893 metabolic acidosis 9.5
894 atrioventricular block 9.5
895 peripheral artery disease 9.5
896 renal fibrosis 9.5
897 oral squamous cell carcinoma 9.5
898 mucosal melanoma 9.5
899 infective endocarditis 9.5
900 withdrawal disorder 9.5
901 interleukin-7 receptor alpha deficiency 9.5
902 autism spectrum disorder 9.5
903 aphasia 9.5
904 pharynx cancer 9.5
905 microscopic colitis 9.5
906 gastroduodenal crohn's disease 9.5
907 basal ganglia calcification 9.5
908 xanthinuria 9.5
909 dowling-degos disease 9.5
910 cardiac arrest 9.5
911 anal fistula 9.5
912 ectopic pregnancy 9.5
913 acrodermatitis chronica atrophicans 9.5
914 punctate palmoplantar keratoderma 9.5
915 penicillin allergy 9.5
916 recessive dystrophic epidermolysis bullosa 9.5
917 physical disorder 9.5
918 cryptococcal meningitis 9.5
919 nodal marginal zone lymphoma 9.5
920 x-linked chondrodysplasia punctata 2 9.5
921 igg4-related disease 9.5
922 hyper ige syndrome 9.5
923 hypogonadotropic hypogonadism 9.5
924 angioimmunoblastic t-cell lymphoma 9.5
925 castleman disease 9.5
926 asymptomatic neurosyphilis 9.5
927 nodular malignant melanoma 9.5
928 pigmentation disease 9.5
929 corneal disease 9.5
930 xerophthalmia 9.5
931 thymus lymphoma 9.5
932 neuroretinitis 9.5
933 pleomorphic lipoma 9.5
934 borderline leprosy 9.5
935 parotitis 9.5
936 legionellosis 9.5
937 meningoencephalitis 9.5
938 steatorrhea 9.5
939 microphthalmia 9.5
940 mastitis 9.5
941 giardiasis 9.5
942 methemoglobinemia 9.5
943 gastric ulcer 9.5
944 kuhnt-junius degeneration 9.5
945 hand, foot and mouth disease 9.5
946 dissociative disorder 9.5
947 strongyloidiasis 9.5
948 pseudopterygium 9.5
949 pinguecula 9.5
950 depersonalization disorder 9.5
951 henoch-schoenlein purpura 9.5
952 pertussis 9.5
953 t cell deficiency 9.5
954 disseminated intravascular coagulation 9.5
955 social phobia 9.5
956 arteriovenous malformation 9.5
957 pneumocystosis 9.5
958 gingival recession 9.5
959 autonomic nervous system disease 9.5
960 hemopericardium 9.5
961 suppurative otitis media 9.5
962 hypertensive heart disease 9.5
963 corneal abscess 9.5
964 retinal vasculitis 9.5
965 hyperandrogenism 9.5
966 cicatricial pemphigoid 9.5
967 nephrosclerosis 9.5
968 familial hyperlipidemia 9.5
969 portal vein thrombosis 9.5
970 gestational diabetes 9.5
971 lyme disease 9.5
972 iron deficiency anemia 9.5
973 pericardial effusion 9.5
974 cryptococcosis 9.5
975 hemosiderosis 9.5
976 dysthymic disorder 9.5
977 aseptic meningitis 9.5
978 paranoid schizophrenia 9.5
979 graves' disease 9.5
980 hepatitis a 9.5
981 acute leukemia 9.5
982 paracoccidioidomycosis 9.5
983 blastomycosis 9.5
984 locked-in syndrome 9.5
985 leiomyoma 9.5
986 quadriplegia 9.5
987 hypochondriasis 9.5
988 alcoholic cardiomyopathy 9.5
989 conduct disorder 9.5
990 carotid stenosis 9.5
991 tinea unguium 9.5
992 branch retinal artery occlusion 9.5
993 central retinal artery occlusion 9.5
994 crescentic glomerulonephritis 9.5
995 acute cystitis 9.5
996 cutaneous porphyria 9.5
997 hairy tongue 9.5
998 plantar wart 9.5
999 familial hypercholesterolemia 9.5
1000 somatization disorder 9.5
1001 algoneurodystrophy 9.5
1002 folic acid deficiency anemia 9.5
1003 toxic labyrinthitis 9.5
1004 azoospermia 9.5
1005 chronic purulent otitis media 9.5
1006 adult-onset still's disease 9.5
1007 sclerosing cholangitis 9.5
1008 cholinergic urticaria 9.5
1009 sporotrichosis 9.5
1010 labyrinthitis 9.5
1011 ectropion 9.5
1012 diffuse scleroderma 9.5
1013 rheumatic fever 9.5
1014 lymphadenitis 9.5
1015 neovascular glaucoma 9.5
1016 peritoneum cancer 9.5
1017 epilepsy 9.5
1018 leiomyosarcoma 9.5
1019 rectum cancer 9.5
1020 vulvar disease 9.5
1021 vaginitis 9.5
1022 essential thrombocythemia 9.5
1023 myeloproliferative neoplasm 9.5
1024 transient cerebral ischemia 9.5
1025 spondylosis 9.5
1026 keratopathy 9.5
1027 nocardiosis 9.5
1028 dyspepsia 9.5
1029 acromegaly 9.5
1030 thrombophilia 9.5
1031 blepharoconjunctivitis 9.5
1032 retinal vascular disease 9.5
1033 splenic abscess 9.5
1034 hematologic cancer 9.5
1035 hemangioma 9.5
1036 opiate dependence 9.5
1037 cervicitis 9.5
1038 tic disorder 9.5
1039 carbohydrate metabolic disorder 9.5
1040 early myoclonic encephalopathy 9.5
1041 skin squamous cell carcinoma 9.5
1042 tropical spastic paraparesis 9.5
1043 myelitis 9.5
1044 syringomyelia 9.5
1045 retinitis 9.5
1046 anal canal adenocarcinoma 9.5
1047 verrucous carcinoma 9.5
1048 vaginal discharge 9.5
1049 pleural empyema 9.5
1050 photoallergic dermatitis 9.5
1051 pituitary adenoma 9.5
1052 placental insufficiency 9.5
1053 insulinoma 9.5
1054 vulvitis 9.5
1055 merkel cell carcinoma 9.5
1056 eosinophilic gastroenteritis 9.5
1057 nodular basal cell carcinoma 9.5
1058 polyradiculoneuropathy 9.5
1059 tinea capitis 9.5
1060 acneiform dermatitis 9.5
1061 neuromuscular disease 9.5
1062 hepatitis e 9.5
1063 clear cell renal cell carcinoma 9.5
1064 hypotrichosis 9.5
1065 mesenchymal chondrosarcoma 9.5
1066 extraskeletal mesenchymal chondrosarcoma 9.5
1067 multiple chemical sensitivity 9.5
1068 endophthalmitis 9.5
1069 mongolian spot 9.5
1070 somatoform disorder 9.5
1071 angiokeratoma 9.5
1072 sebaceous adenocarcinoma 9.5
1073 epidermolysis bullosa dystrophica 9.5
1074 chronic inflammatory demyelinating polyradiculoneuropathy 9.5
1075 intestinal disease 9.5
1076 paget's disease of bone 9.5
1077 lung oat cell carcinoma 9.5
1078 schizoaffective disorder 9.5
1079 dystonia 9.5
1080 tricuspid valve prolapse 9.5
1081 pulmonary valve stenosis 9.5
1082 spinal stenosis 9.5
1083 lung lymphoma 9.5
1084 hepatoblastoma 9.5
1085 acth-secreting pituitary adenoma 9.5
1086 subacute thyroiditis 9.5
1087 diverticulitis 9.5
1088 muscular atrophy 9.5
1089 delusional disorder 9.5
1090 osteochondrosis 9.5
1091 myocarditis 9.5
1092 peritonitis 9.5
1093 appendicitis 9.5
1094 cyclothymic disorder 9.5
1095 pellagra 9.5
1096 retinal artery occlusion 9.5
1097 collagen disease 9.5
1098 sezary's disease 9.5
1099 duodenitis 9.5
1100 gastroduodenitis 9.5
1101 substance-induced psychosis 9.5
1102 tongue cancer 9.5
1103 vascular dementia 9.5
1104 smallpox 9.5
1105 rubella 9.5
1106 intermediate coronary syndrome 9.5
1107 cervix uteri carcinoma in situ 9.5
1108 ritter's disease 9.5
1109 macroglobulinemia 9.5
1110 cutaneous leishmaniasis 9.5
1111 ocular hypertension 9.5
1112 mechanical strabismus 9.5
1113 exophthalmos 9.5
1114 epiglottitis 9.5
1115 acute myocardial infarction 9.5
1116 intracranial hypertension 9.5
1117 otitis externa 9.5
1118 bronchiectasis 9.5
1119 necrotizing fasciitis 9.5
1120 biliary tract disease 9.5
1121 hypersensitivity vasculitis 9.5
1122 polyarteritis nodosa 9.5
1123 miliary tuberculosis 9.5
1124 toxoplasmosis 9.5
1125 albinism 9.5
1126 bap1 tumor predisposition syndrome 9.5
1127 c3 glomerulopathy 9.5
1128 cleidocranial dysplasia spectrum disorder 9.5
1129 47, xxy 9.5
1130 acquired hemophilia a 9.5
1131 acute articular rheumatism 9.5
1132 alopecia totalis 9.5
1133 aminoaciduria 9.5
1134 black hairy tongue 9.5
1135 cataract-glaucoma 9.5
1136 cervical intraepithelial neoplasia 9.5
1137 demodicidosis 9.5
1138 drug reaction with eosinophilia and systemic symptoms 9.5
1139 eosinophilic enteropathy 9.5
1140 erythroplakia 9.5
1141 exercise-induced anaphylaxis 9.5
1142 familial episodic pain syndrome 9.5
1143 familial glucocorticoid deficiency 9.5
1144 fibromatosis 9.5
1145 gigantism 9.5
1146 glucagonoma 9.5
1147 grover's disease 9.5
1148 hemorrhagic proctocolitis 9.5
1149 htlv-1 associated myelopathy/tropical spastic paraparesis 9.5
1150 keratosis follicularis spinulosa decalvans 9.5
1151 kikuchi disease 9.5
1152 lewis-sumner syndrome 9.5
1153 lichen planus pemphigoides 9.5
1154 lichen planus pigmentosus 9.5
1155 linear iga disease 9.5
1156 malakoplakia 9.5
1157 mercury poisoning 9.5
1158 mondor disease 9.5
1159 mycobacterium abscessus 9.5
1160 mycobacterium fortuitum 9.5
1161 neurosyphilis 9.5
1162 oncogenic osteomalacia 9.5
1163 papular mucinosis 9.5
1164 periodontal ehlers-danlos syndrome 9.5
1165 pityriasis lichenoides et varioliformis acuta 9.5
1166 precocious puberty 9.5
1167 pseudo-turner syndrome 9.5
1168 retroperitoneal fibrosis 9.5
1169 scleromyxedema 9.5
1170 secondary adrenal insufficiency 9.5
1171 spastic paraparesis 9.5
1172 t-cell/histiocyte rich large b cell lymphoma 9.5
1173 transverse myelitis 9.5
1174 childhood myocerebrohepatopathy spectrum 9.5
1175 hereditary xanthinuria 9.5
1176 atrial fibrillation and stroke 9.5
1177 dysphagia 9.5
1178 foot drop 9.5
1179 hereditary neuropathies 9.5
1180 hypotonia 9.5
1181 porokeratotic eccrine ostial and dermal duct nevus 9.5
1182 chronic cutaneous lupus erythematosus 9.5
1183 rare rheumatologic disease 9.5
1184 acute transverse myelitis 9.5
1185 cerebrofacial arteriovenous metameric syndrome 9.5
1186 nevus of ota 9.5
1187 pulmonary arterial hypertension associated with another disease 9.5
1188 herpetiform pemphigus 9.5
1189 primary cutaneous lymphoma 9.5
1190 isoniazid toxicity 9.5
1191 idiopathic nephrotic syndrome 9.5
1192 phalangeal microgeodic syndrome 9.5
1193 epstein-barr virus-associated malignant lymphoproliferative disorder 9.5
1194 myospherulosis 9.5
1195 acquired methemoglobinemia 9.5
1196 cutaneous pseudolymphoma 9.5
1197 chronic enteropathy associated with slco2a1 gene 9.5
1198 polyarticular juvenile idiopathic arthritis 9.5
1199 deep dermatophytosis 9.5
1200 zinc-responsive necrolytic acral erythema 9.5
1201 epidermolytic nevus 9.5
1202 granulomatous mastitis 9.5
1203 argyria 9.5
1204 disorder of purine metabolism 9.5
1205 rare genetic skin disease 9.5
1206 lichen amyloidosis 9.5
1207 serotonin syndrome 9.5
1208 superficial pemphigus 9.5
1209 obsolete: methotrexate poisoning 9.5
1210 renal dysplasia 9.5
1211 discrete papular lichen myxedematosus 9.5
1212 premature aging 9.5
1213 pemphigus erythematosus 9.5
1214 inherited epidermolysis bullosa 9.5
1215 hereditary palmoplantar keratoderma 9.5
1216 acrokeratoderma 9.5
1217 hepatosplenic t-cell lymphoma 9.5
1218 cardiogenic shock 9.5
1219 type ii mixed cryoglobulinemia 9.5
1220 uremic pruritus 9.5
1221 refractory anemia 9.5
1222 streptococcal toxic-shock syndrome 9.5

Graphical network of the top 20 diseases related to Pustulosis of Palm and Sole:



Diseases related to Pustulosis of Palm and Sole

Symptoms & Phenotypes for Pustulosis of Palm and Sole

UMLS symptoms related to Pustulosis of Palm and Sole:


pruritus, exanthema, psoriasiform rash

Drugs & Therapeutics for Pustulosis of Palm and Sole

Drugs for Pustulosis of Palm and Sole (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 467, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Esomeprazole Approved, Investigational Phase 4 119141-88-7, 161796-78-7, 161973-10-0 9568614 4594
2
Dapsone Approved, Investigational Phase 4 80-08-0 2955
3
Clobetasol Approved, Experimental, Investigational Phase 4 25122-46-7, 25122-41-2 32798 5311051
4
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
5
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754
6
Hydrocortisone acetate Approved, Vet_approved Phase 4 50-03-3
7
Clocortolone Approved Phase 4 34097-16-0, 4828-27-7 5282493 5311052
8
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
9
Sodium citrate Approved, Investigational Phase 4 68-04-2
10
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
11
carbamide peroxide Approved Phase 4 124-43-6
12 Orange Approved Phase 4
13 Strawberry Approved Phase 4
14 Artichoke Approved Phase 4
15
Sorafenib Approved, Investigational Phase 4 284461-73-0 216239 406563
16
Adalimumab Approved Phase 4 331731-18-1 16219006
17
Certolizumab pegol Approved Phase 4 428863-50-7
18
Desoximetasone Approved Phase 4 382-67-2 5311067
19
Tofacitinib Approved, Investigational Phase 4 477600-75-2
20
Zinc Approved, Investigational Phase 4 7440-66-6 32051
21
Mercaptopurine Approved Phase 4 50-44-2 667490
22
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
23
Sotalol Approved Phase 4 959-24-0, 3930-20-9 5253
24 Ixekizumab Approved, Investigational Phase 4 1143503-69-8
25
tannic acid Approved Phase 4 1401-55-4
26
Benzocaine Approved, Investigational Phase 4 94-09-7, 1994-09-7 2337
27
Ustekinumab Approved, Investigational Phase 4 815610-63-0
28
Metformin Approved Phase 4 657-24-9 4091 14219
29 Vedolizumab Approved Phase 4 943609-66-3
30
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
31
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
32
Salicylic acid Approved, Investigational, Vet_approved Phase 4 69-72-7 338
33
Capsaicin Approved Phase 4 404-86-4 1548943
34
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 22737-96-8, 11103-57-4, 68-26-8 9904001 445354
35
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
36
Glycine Approved, Nutraceutical, Vet_approved Phase 4 56-40-6 750
37
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
38
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 5280453 134070
39 Retinol palmitate Phase 4
40 retinol Phase 4
41 Antiparasitic Agents Phase 4
42 Antiprotozoal Agents Phase 4
43 Antimalarials Phase 4
44 Tin Fluorides Phase 4
45 Heptavalent Pneumococcal Conjugate Vaccine Phase 4
46 Immunoglobulin A Phase 4
47 Halobetasol Phase 4
48
Chondroitin Phase 4 9007-27-6 53477707
49 Hydrocortisone 17-butyrate 21-propionate Phase 4
50 Hydrocortisone hemisuccinate Phase 4
51 Hydrocortisone-17-butyrate Phase 4
52 Clocortolone pivalate Phase 4
53 Olive Phase 4
54 Omega 3 Fatty Acid Phase 4
55 Chelating Agents Phase 4
56 Natriuretic Agents Phase 4
57 Citrate Phase 4
58 diuretics Phase 4
59 Anticoagulants Phase 4
60 Chlorpheniramine, phenylpropanolamine drug combination Phase 4
61 Lidocaine, Prilocaine Drug Combination Phase 4
62 Neurotransmitter Agents Phase 4
63 Antipyretics Phase 4
64 Cyclosporins Phase 4
65 Adrenergic Agents Phase 4
66 Autonomic Agents Phase 4
67 Protein Kinase Inhibitors Phase 4
68 Cyclooxygenase Inhibitors Phase 4
69 Adrenergic beta-Antagonists Phase 4
70 Adrenergic Antagonists Phase 4
71 Sympatholytics Phase 4
72 Anti-Arrhythmia Agents Phase 4
73 Sodium Channel Blockers Phase 4
74 Diuretics, Potassium Sparing Phase 4
75 Mesalamine Phase 4 89-57-6
76 Fibrinolytic Agents Phase 4
77 Platelet Aggregation Inhibitors Phase 4
78 Vaccines Phase 4
79 Micronutrients Phase 4
80 Trace Elements Phase 4
81 Respiratory System Agents Phase 4
82 Vitamins Phase 4
83 Nutrients Phase 4
84 Anti-Asthmatic Agents Phase 4
85 Betamethasone Valerate Phase 4 2152-44-5
86 Betamethasone sodium phosphate Phase 4
87 Betamethasone-17,21-dipropionate Phase 4
88 Calcium, Dietary Phase 4
89 Calcipotriene Phase 4
90 Bone Density Conservation Agents Phase 4
91 Betamethasone benzoate Phase 4
92 Antifungal Agents Phase 4
93 Emollients Phase 4
94 Cayenne Phase 4
95 Antipruritics Phase 4
96
Methoxsalen Approved Phase 3 298-81-7 4114